Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Samit Chatterjee
Low Level Endogenous Prostate-Specific Membrane Antigen (PSMA) Expression in Non-Prostatic Tumor Xenografts Is Sufficient for in Vivo Tumor Targeting and Imaging
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
In Vivo Evaluation of an Engineered Cyclotide as Specific CXCR4 Imaging Reagent
Chemistry - A European Journal
Organic Chemistry
Catalysis
Chemistry
Related publications
Hetero-Bivalent Imaging Agents for Simultaneous Targeting Prostate-Specific Membrane Antigen (PSMA) and Hepsin
PET Imaging of Prostate Cancer Xenografts With a Highly Specific Antibody Against the Prostate-Specific Membrane Antigen
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Crystal Structure of Prostate-Specific Membrane Antigen, a Tumor Marker and Peptidase
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Engineering a Prostate-Specific Membrane Antigen-Activated Tumor Endothelial Cell Prodrug for Cancer Therapy
Science Translational Medicine
Medicine
Prostate-Specific Antigen Adjusted for Total Prostatic Tumor Volume as a Predictor for Outcome After Radical Prostatectomy
Prostate Cancer and Prostatic Diseases
Cancer Research
Oncology
Urology
Maximum Tumor Diameter Is an Independent Predictor of Prostate-Specific Antigen Recurrence in Prostate Cancer
Modern Pathology
Forensic Medicine
Pathology
Prostate-Specific Membrane Antigen Expression Is a Potential Prognostic Marker in Endometrial Adenocarcinoma
Cancer Epidemiology Biomarkers and Prevention
Medicine
Epidemiology
Oncology
Detection of Prostate-Specific Membrane Antigen on HUVECs in Response to Breast Tumor-Conditioned Medium
International Journal of Oncology
Cancer Research
Oncology
Prostate-Specific Membrane Antigen (PSMA) Assembles a Macromolecular Complex Regulating Growth and Survival of Prostate Cancer Cells “In Vitro” and Correlating With Progression “In Vivo”
Oncotarget
Oncology
